← Every company
Kodiak Sciences Inc Patents
What Kodiak Sciences Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
KOD on carbonthat →Filings on file
30
Granted
0
Still pending
30
Filed under
3 names
30 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS OF TREATING AN EYE DISORDERA61P 27/02, C07K 17/08, A61K 47/58, A61K 47/605, A61K 47/6845, A61K 47/595, A61P 27/00, A61K 9/0019, A61K 9/0048, A61K 9/0051, A61K 9/08, A61K 47/02, A61K 47/26, A61K2039/505, A61K2039/54, A61K2039/545Filed as KODIAK SCIENCES INC.2026-05-26Jason Ehrlich | pending |
| COMPOSITIONS OF CONJUGATED AND UNCONJUGATED PROTEINSA61K 47/60, A61K 47/6847, A61K 9/0048, C07K 16/22Filed as KODIAK SCIENCES INC.2025-12-04Daniel Victor Perlroth | pending |
| METHODS FOR ANALYZING MIXED COMPOSITIONS OF PROTEIN AND PROTEIN CONJUGATESG01N 1/405, B01D 15/125, B01D 15/1871, B01D 15/34, B01D 15/362, G01N 1/4077, G01N 30/14, G01N 30/46, G01N2001/4088, G01N2030/027Filed as KODIAK SCIENCES INC.2025-12-04Wah Yuen To | pending |
| CYCLIC ALKYNES AND DERIVATIVES THEREOFFiled as KODIAK SCIENCES INC.2025-09-22QIANLI MENG | pending |
| TARGETED DRUG POLYMER CONJUGATESFiled as KODIAK SCIENCES INC.2025-09-19DANIEL VICTOR PERLROTH | pending |
| METHODS OF TREATING EYE DISORDERSFiled as KODIAK SCIENCES INC.2025-09-18DANIEL VICTOR PERLROTH | pending |
| ANTIBODIES TO HTRA1 AND CONJUGATES THEREOFFiled as Kodiak Sciences Inc.2025-08-27Daniel Victor PERLROTH | pending |
| ORGANIC COMPOUNDS AS NLRP3 INHIBITORSC07D 401/14, A61K 31/501, A61K 31/502, A61K 31/5025, C07D 401/12, C07D 405/14, C07D 409/14, C07D 471/04, C07D 471/10, C07D 487/04, C07D 491/048Filed as KODIAK SCIENCES, INC.2025-07-01Qianli Meng | pending |
| METHOD OF CONCENTRATING A SOLUTION OR FORMULATIONA61K 9/0019, C07K 16/248, A61K 47/58, A61K 9/19, A61K 39/39591, A61K 47/26, C07K 1/14, C07K 16/22, C07K2317/24, C07K2317/31, C07K2317/51, C07K2317/515, C07K2317/565, C07K2317/76, C07K2319/00Filed as Kodiak Sciences Inc.2025-03-21Wah Yuen To | pending |
| CELL-SURFACE-TARGETING-DOMAIN-POLYMER-PAYLOAD CONJUGATEFiled as KODIAK SCIENCES INC.2025-02-27LILI LIU | pending |
| ENGINEERED COMPLEMENT INHIBITOR PROTEINSFiled as KODIAK SCIENCES INC.2025-02-27DOLLY SHUO-TEH CHANG | pending |
| METHODS OF TREATING EYE DISORDERSFiled as KODIAK SCIENCES INC.2025-01-31DANIEL VICTOR PERLROTH | pending |
| NLRP3 INHIBITORSA61K 45/06, C07D 405/06, A61P 9/10, A61K 31/341, A61K 31/351, A61K 31/397, A61K 31/4025, A61K 31/415, A61K 31/4155, A61K 31/4355, A61K 31/496, A61K 31/64, C07D 231/18, C07D 307/64, C07D 307/68, C07D 403/06, C07D 405/12, C07D 407/12, C07D 491/048, A61K2300/00Filed as Kodiak Sciences Inc.2025-01-03Jianhua Chao | pending |
| FORMULATIONS FOR DUAL VEGF/IL-6 INHIBITORS, ANTI-VEGF ANTIBODIES, AND CONJUGATES THEREOFFiled as KODIAK SCIENCES INC.2024-12-04ANDREAS SEBASTIAN ZURBRIGGEN | pending |
| CYCLIC ALKYNES AND DERIVATIVES THEREOFFiled as Kodiak Sciences Inc.2024-09-20Qianli Meng | pending |
| METHODS OF TREATING MACULAR EDEMA SECONDARY TO INFLAMMATION (MESI)Filed as KODIAK SCIENCES INC.2024-09-20Daniel Victor Perlroth | pending |
| TARGETED DRUG POLYMER CONJUGATESFiled as Kodiak Sciences Inc.2024-09-20Daniel Victor Perlroth | pending |
| METHODS OF TREATING EYE DISORDERSFiled as KODIAK SCIENCES INC.2024-09-20Daniel Victor Perlroth | pending |
| METHODS OF TREATING EYE DISORDERSFiled as KODIAK SCIENCES INC.2024-09-20Daniel Victor Perlroth | pending |
| IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOFA61P 3/10, C07K 16/248, A61K 47/6883, A61K 47/60, A61K 47/59, A61P 27/02, A61K 9/0048, A61K 9/08, C07K 14/485, C07K 14/5412, C07K 14/705, C07K2317/31, C07K2317/52, C07K2317/524, C07K2317/526, C07K2317/565, C07K2317/71, C07K2317/73, C07K2317/76, C07K2317/92, C07K2319/00, C07K2319/30, C12N 15/62Filed as KODIAK SCIENCES INC.2024-06-06Rachel D. Jacobson | pending |
| FORMULATIONS FOR DUAL VEGF/IL-6 INHIBITORS, ANTI-VEGF ANTIBODIES, AND CONJUGATES THEREOFFiled as KODIAK SCIENCES INC.2024-06-06Andreas Sebastian Zurbriggen | pending |
| METHODS FOR ANALYZING MIXED COMPOSITIONS OF PROTEIN AND PROTEIN CONJUGATESFiled as KODIAK SCIENCES INC.2024-06-06WAH YUEN TO | pending |
| COMPOSITIONS OF CONJUGATED AND UNCONJUGATED PROTEINSFiled as KODIAK SCIENCES INC.2024-06-06DANIEL VICTOR PERLROTH | pending |
| HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERSA61K 51/065, A61K 47/58, A61K 47/6881, A61K 31/74, A61K 49/0054, C08F 2/04, C08F 2/06, C08F 2/50, C08F 20/18, C08F 20/26, C08F 230/02, C08F2438/01, C08F2500/03Filed as Kodiak Sciences Inc.2024-04-17Stephen A. Charles | pending |
| ENGINEERED COMPLEMENT INHIBITOR PROTEINSFiled as Kodiak Sciences Inc.2024-02-29Catherine M. Cho | pending |
| CELL-SURFACE-TARGETING-DOMAIN-POLYMER-PAYLOAD CONJUGATEFiled as Kodiak Sciences Inc.2024-02-29Lili Liu | pending |
| ANTIBODIES TO HTRA1 AND CONJUGATES THEREOFFiled as KODIAK SCIENCES INC.2024-02-26DANIEL, VICTOR PERLROTH | pending |
| MULTIVALENT TRAP-ANTIBODY FUSIONSFiled as KODIAK SCIENCES INC.2024-02-26DANIEL, VICTOR PERLROTH | pending |
| METHODS OF TREATING EYE DISORDERSFiled as KODIAK SCIENCES INC.2024-02-02Daniel Victor Perlroth | pending |
| ORGANIC COMPOUNDS AS NLRP3 INHIBITORSFiled as KODIAK SCIENCES INC.2024-01-02QIANLI MENG | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on KOD
Company overviewEverything on KOD in one place, with the price.SEC filingsWhat KOD's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat KOD's own officers and directors buy and sell.Executive payWhat KOD awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in KOD.Funds holding itWhich funds and ETFs hold KOD, and how big a bet.